Clinical Trials Search Results

11 - 20 of 83 Results

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

This study will test the theory that therapy designed for each individual's tumor will improve outcomes over standard of care.

HER 2 Negative, ER/PR Positive - Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA)

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA)
11 - 20 of 83 Results